- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02223676
Clinical Pharmacists in the Emergency Department
May 17, 2018 updated by: Randers Regional Hospital
Is Length of Stay in the Emergency Department Reduced When Clinical Pharmacists Conduct Medication History? - a Cluster Randomized Study
The purpose of this study is to investigate the effect of implementing clinical pharmacists in the Emergency Department Team at Randers Regional Hospital.
The clinical pharmacists conduct medication history, make medical interaction screenings, -reconciliations and -reviews on unscheduled patients admitted to the Emergency Department during daytime.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
448
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Region Midt
-
Randers, Region Midt, Denmark, 8900
- Randers Regional Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- unscheduled patients admitted to the Emergency Department at Randers Regional Hospital at weekdays during daytime (9 am to 16.15 pm)
- 4 or more drugs prescribed
Exclusion Criteria:
- patients triage red
- patients who cannot give informed consent
- terminal patients
- patients admitted to detoxification
- patients refered to the acute outpatient department
- patients remaining in the Emergency Department overnight
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention
Clinical pharmacists conduct medication history
|
pharmacists conduct medication history before the physician interviews the patient and does not spend time on conducting medical history
|
NO_INTERVENTION: Control
standard procedures for admission is followed
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Emergency Department Length of stay
Time Frame: From arrival to the Emergency Department to either admission or discharge, which in average will be 6 hours.
|
From arrival to the Emergency Department to either admission or discharge, which in average will be 6 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time from patient arrival to the treatment schedule is ready
Time Frame: From arrival to the Emergency Department to either admission or discharge, which in average will be 6 hours.
|
From arrival to the Emergency Department to either admission or discharge, which in average will be 6 hours.
|
|
Patient safety
Time Frame: From arrival to the Emergency Department to either admission or discharge, which in average will be 6 hours.
|
Number of recommended changes in drugs or dosage per patient.
The changes are rated according to a PCNE-classification for drug-related problems.
|
From arrival to the Emergency Department to either admission or discharge, which in average will be 6 hours.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The impact of the intervention in the Emergency Department on the existing medication review by clinical pharmacist at the acute ward
Time Frame: 1-3 days after admission to Emergency Department when the secondary medication review takes place
|
We estimate whether the intervention is time-saving (by recording and comparing time spent for secondary/excisting medication review at the acute ward between patients allocated to the intervention and control group, respectively) and reduce the workload of the clinicians (number and kind of interventions at secondary medication review in the two groups)
|
1-3 days after admission to Emergency Department when the secondary medication review takes place
|
The impact of the intervention in the Emergency Department on the dispensing of medicine (done by nurses)
Time Frame: During actual admission to the Emergency Department and the period after inclusion of patients
|
time used and the possibility of substitutions
|
During actual admission to the Emergency Department and the period after inclusion of patients
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (ACTUAL)
June 1, 2014
Study Completion (ACTUAL)
December 1, 2014
Study Registration Dates
First Submitted
January 7, 2014
First Submitted That Met QC Criteria
August 21, 2014
First Posted (ESTIMATE)
August 22, 2014
Study Record Updates
Last Update Posted (ACTUAL)
May 21, 2018
Last Update Submitted That Met QC Criteria
May 17, 2018
Last Verified
August 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-16-02-379-13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medication Reconciliation
-
The University Clinic of Pulmonary and Allergic...University of LjubljanaTerminatedMedication ReconciliationSlovenia
-
Rennes University HospitalCompleted
-
PictureRx, LLCUniversity of CincinnatiCompletedMedication ReconciliationUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...Recruiting
-
Indiana UniversityAgency for Healthcare Research and Quality (AHRQ); Regenstrief Institute, Inc. and other collaboratorsCompletedMedication ReconciliationUnited States
-
Lille Catholic UniversityCompletedElderly | Medication Reconciliation | Patient ReadmissionFrance
-
Rennes University HospitalEcole des Hautes Etudes en Santé PubliqueCompletedMedication Reconciliation at DischargeFrance
-
Brigham and Women's HospitalCompletedMedication ReconciliationUnited States
-
Centre d'Investigation Clinique et Technologique...CompletedMedication ReconciliationFrance
-
The Cleveland ClinicCompletedMedication Reconciliation Between Patients' Self Report and Electronic Medical Record ListUnited States
Clinical Trials on Clinical pharmacists conduct medication history
-
Cedars-Sinai Medical CenterNational Institutes of Health (NIH); National Institute on Aging (NIA)Completed
-
Indiana UniversityCompletedMedication Histories in Outpatient Clinic PatientsUnited States
-
PictureRx, LLCUniversity of CincinnatiCompletedMedication ReconciliationUnited States
-
Hospital Pharmacy of North Norway TrustUniversity Hospital of North Norway; University of Tromso; Nordlandssykehuset HF and other collaboratorsActive, not recruitingEmergency Department | Clinical PharmacistNorway
-
Diabetes Foundation, IndiaJohns Hopkins University; National Diabetes Obesity and Cholesterol FoundationRecruiting
-
University Hospital, GhentCompletedKnee Arthrodesis With Intramedullary NailBelgium
-
First Affiliated Hospital Xi'an Jiaotong UniversityCompletedHepatocellular Carcinoma | Survival | Hepatitis B Virus
-
First Affiliated Hospital Xi'an Jiaotong UniversityThe First Affiliated Hospital of Zhengzhou UniversityCompletedCOVID-19 | Organ Transplantation
-
Universitas Negeri SemarangUniversitas Diponegoro; Ministry of Research, Technology and Higher Education...CompletedTour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels (TdBTS)Inflammatory Response | Heart Arrest | Oxidative Stress | Sport InjuryIndonesia
-
University of Michigan Rogel Cancer CenterAstraZenecaTerminatedChronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Multiple Chronic ConditionsUnited States